Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $25.6 million versus the consensus estimate of $24.05 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.